What is Synjardy?

Synjardy is a combination of two medications, empagliflozin and metformin, for the treatment of type 2 diabetes. Empagliflozin removes excess sugar through the kidneys, while metformin blocks the creation of glucose in the liver and its absorption in the intestines. Synjardy is not meant to treat type 1 diabetes or diabetic ketoacidosis. Synjardy comes in tablet form, to be taken twice a day; it should be taken with meals to avoid stomach upset. Lactic acidosis may occur while taking Synjardy; the risk is increased with alcohol abuse, liver or kidney impairment, dehydration, sepsis, or acute congestive heart failure. Lactic acidosis can cause shock, coma, or death; if while taking this drug you experience flu-like symptoms, fruity breath, problems with urination, myalgias, breathing problems, increased sleepiness, or unusual muscle or stomach pain, consult your doctor right away. Nursing mothers should not use Synjardy. It is not known if Synjardy is safe during pregnancy. 

Continue Learning about Type 2 Diabetes Treatment

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.